Profund Advisors’s Avadel Pharmaceuticals AVDL Stock Holding History

Profund Advisors’s Portfolio AVDL Stock Details AVDL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-13,354	Closed	-$288K	–	1112
2025 Q4	$288K	Sell	13,354 -2,912	-18%	-$56.5K	0.01%	906
2025 Q3	$248K	Buy	+16,266	New	+$212K	0.01%	855

Other funds holding AVDL

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Profund Advisors's AVDL Position: Q1 2026 in Review

Profund Advisors sold out of Avadel Pharmaceuticals (AVDL) in Q1 2026, closing a stake of 13,354 shares — an estimated $288K sold.

Profund Advisors first reported a position in AVDL in Q3 2025 and held it in 2 quarters. The position peaked at $288K in Q4 2025. 2 funds tracked by Wall St. Rank hold AVDL as of Q1 2026.

Profund Advisors reported no remaining Avadel Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
Profund Advisors sold 13,354 Avadel Pharmaceuticals shares in Q1 2026, an estimated $288K.
Profund Advisors first reported a position in Avadel Pharmaceuticals in Q3 2025 and held it in 2 quarters.
Profund Advisors's Avadel Pharmaceuticals position peaked at $288K in Q4 2025.
2 funds tracked by Wall St. Rank held Avadel Pharmaceuticals as of Q1 2026.

Based on Profund Advisors's 13F filing for Q1 2026, filed 27 Apr 2026.